Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
Abbreviated, abroad, absent, accreted, accrual, alive, ANDA, annum, arm, assigned, assignment, bankruptcy, borrow, Boston, breach, broaden, buy, Cambridge, Canada, CompanyJack, cyclotron, dedicated, defend, deliverable, died, dispensing, dissolution, elapse, electronic, endpoint, enterprise, exemption, facilitating, factor, felt, FIN, formal, hand, IBMTR, imposed, inexpensive, inherently, insolvency, IV, launch, Leerink, length, level, lifted, lifting, likelihood, lowest, managerial, mandatory, margin, marketplace, mid, negated, ninety, open, OTC, overdraft, overhead, people, permission, Pink, predominately, preserve, progression, proportion, Quantification, quantify, quoted, Radiochemical, reassigned, recalculated, recalculation, reclassified, recommend, regional, relist, reluctant, reorganization, repeal, repeat, reset, restoration, rolling, shorten, simple, SPA, sterilization, stored, sue, suit, Supplementary, surrender, surrogate, Swann, thereunder, tier, timeline, Trace, track, tracking, undelivered, undergone, undeterminable, unexpected, Union, unlisted, unmodified, unused, user, USPN, vacant, Velcade, waste, web
Removed:
amortization, anderson, anniversary, antibody, antidilutive, antigen, awarded, bind, binding, biological, blocked, collaborator, collected, continually, continuation, deferring, delayed, delivered, destroy, enhance, enrolling, establishing, frequently, fusion, gemcitabine, genetically, immune, lawsuit, linked, locate, monoclonal, NHL, North, occurring, operational, ovary, pancreatic, pertaining, produced, rapidly, remain, spending, sublease, subordinated, supplement, surface, tolerate, tolerated, unbound, unpaid, viable
Filing tables
Filing exhibits
PARD similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Exhibit 32.1
Certification of Annual Report
I, Jack L. Bowman, Chairman and Chief Executive Officer, of NeoRx Corporation (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
- 1.
- the Annual Report on Form 10-K for the Company for the year ended December 31, 2003, (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (12 U.S.C. 78m or 78o(d)); and
- 2.
- the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 9, 2004 | By: | /s/ JACK L BOWMAN Jack L. Bowman |
Certification of Annual Report